genomics

  • Bio
    Genetics startup Genos wants to pay you for your DNA data

    Genetics startup Genos wants to pay you for your DNA data

    The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since then, leading to a new breed of consumer genetics startups taking a deeper dive into all the double helix’s that make up you. Genos is one of those startups using a next-generation… Read More

  • 23andMe reportedly no longer working on next-gen sequencing

    23andMe reportedly no longer working on next-gen sequencing

    23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-based lab, according to BuzzFeed, which first reported the news. By our own count based on LinkedIn, at least five members of the lab have been let go, including its chief medical officer, Dr. Read More

  • What happens if we live to be 150? Crunch Network

    What happens if we live to be 150?

    Humans have lived for approximately 8,000 generations, but only in the past four has life expectancy taken dramatic leaps upward thanks mostly to societies addressing some of the most basic life issues. In 1907, the average human life expectancy was 46 years; in 1957, it rose to 66; in 2007, it reached 76. But I predict we won’t stop there. Read More

  • Bio
    Rex Animal Health is using genomics to keep livestock healthy

    Rex Animal Health is using genomics to keep livestock healthy

    A startup called Rex Animal Health wants to protect livestock from illnesses that can quickly turn into epidemics, and help farmers breed animals with the healthiest and most attractive traits. Today at Disrupt SF, Rex unveiled technology to help veterinarians provide clinical support at the point on the farm, and predict the genetic causes of problematic traits in their herds, and in the… Read More

  • Is enterprise genomics good enough yet? Crunch Network

    Is enterprise genomics good enough yet?

    Genomics will make the dream of targeted therapies a reality, which will have a massive health and economic impact. Yet most large life science enterprises, from pharma to providers, have yet to fully adopt genomics as part of their toolkit for clinical trials, development, commercialization and diagnostics. Read More

  • Innovation in genomics and the future of medtech  Crunch Network

    Innovation in genomics and the future of medtech 

    The field of medicine is in the process of being profoundly transformed by new technologies; much of this transformation comes from exciting advances in genomics. Although genomics is relatively unknown to the general public, innovations in the field have started to make headlines: Genetic testing startup 23andMe, the “gene editing” technology CRISPR and the ambitious 100,000… Read More

  • For less than $1,000 you can now pull up your entire genome on your smartphone

    For less than $1,000 you can now pull up your entire genome on your smartphone

    Veritas Genetics was one of the first companies to sequence the entire human genome for less than $1,000 in 2015. It’s now taken that technology a step further by delivering the results of your entire genome in an app. To put in context just how radical this is, consider the first attempt at whole human genome sequencing required $3.7 billion to produce in 2001. It wasn’t until… Read More

  • At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away

    At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away

    DNA sequencing startup Sure Genomics wants to help you learn about your entire genome at the click of a button. Today, the startup opened up an at-home service to the public, enabling consumers to get their full DNA sequence with a single saliva test. Some of the bigger companies in the personal genome space like Knome and Illumina’s Every Genome offer an all-encompassing service for tens… Read More

  • Warburg Pincus, Illumina & Sutter Hill Launch New Genomics Co. Helix With $100M

    Warburg Pincus, Illumina & Sutter Hill Launch New Genomics Co. Helix With $100M

    Based in San Francisco, Helix is aiming to be a central repository for personalized genetic information and provide a marketplace for applications potentially like the ones developed in Illumina’s genome-based accelerator program. Read More